ESSA Pharma (EPIX)
(Delayed Data from NSDQ)
$6.43 USD
-0.03 (-0.46%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $6.28 -0.15 (-2.33%) 6:12 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 12/10/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 38.46% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.71 |
Next Year | -0.97 |
EPS (TTM) | -0.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.26 | -0.71 | -0.97 |
# of Estimates | 4 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | -0.66 | NA |
High Estimate | -0.16 | -0.23 | -0.66 | -0.62 |
Low Estimate | -0.25 | -0.29 | -0.75 | -1.54 |
Year ago EPS | -0.12 | -0.14 | -0.60 | -0.71 |
Year over Year Growth Est. | -75.00% | -85.71% | -18.33% | -37.32% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.26 | -0.71 | -0.97 |
7 Days Ago | -0.21 | -0.26 | -0.71 | -0.97 |
30 Days Ago | -0.21 | -0.26 | -0.71 | -0.97 |
60 Days Ago | -0.25 | -0.42 | -0.83 | -1.09 |
90 Days Ago | -0.25 | -0.42 | -0.83 | -1.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.26 | -0.71 | -0.97 |
Zacks Consensus Estimate | -0.21 | -0.26 | -0.71 | -0.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.20 | -0.14 | -0.12 | NA |
Estimate | -0.26 | -0.19 | -0.17 | -0.22 | NA |
Difference | 0.10 | -0.01 | 0.03 | 0.10 | 0.06 |
Surprise | 38.46% | -5.26% | 17.65% | 45.45% | 24.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more